ArticleTranslational cancer research2020
"Prostate management" under MRI-guidance: 7 years of improvements.
Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Comparing and Combining Artificial Intelligence and Spectral/Statistical Approaches for Elevating Prostate Cancer Assessment in a Biparametric MRI: A Pilot Study.Diagnostics (Basel, Switzerland) · 2025Article
- Variation in Clinically Significant Prostate Cancer on Fusion Biopsy of PI-RADS 3-5 Lesions Based on Ethnicity.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this retrospective study is to represent our experience in percutaneous MRI-guided prostate procedures (biopsy and cryotherapy), and to discuss the improvement achieved in standardization of these procedures leading to a gain in feasibility and reproducibility of the technique used by urologists while handling MRI-environment.
methodsFrom 2009 to 2018, 62 patients required MRI-guided prostate procedures in our institute. Throughout 9 years of experience, we have achieved an improvement of the technique used to protect the rectum and the urethra which increased accuracy and reproducibility. Procedures were performed by both urologists and radiologists under MRI guidance (Magnetom-Espree and Magnetom-Aera; Siemens, Erlangen, Germany) in a dedicated hybrid-room.
resultsUtilization of a patient stand and an acrylic needle-guided template created by Noras Company allowed standardization of the technique used and thus allowed an increase in accuracy. In order to protect the rectum, we inject patient's own blood into the Denonvillier's fascia which helps to dissect away the prostate from the rectum. In addition, the use of a thermocouple assistance probe placed in the urethral sphincter enabled urethral temperature monitoring during the entire procedure. The aim of temperature monitoring is to protect the urethra from possible thermal injuries.
conclusionsImprovements achieved in our technique used in MRI guided prostate procedures may allow wide spread use of this technique in both radiological and urological fields and opens opportunities in the development of focal therapy of the prostate using MRI-guidance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.